DuraGen® ID2205Recalls & reported problems
Integra Lifesciences Corporation · DuraGen® Dural Graft Matrix 2in x 2in, 5cm x 5cm · Class 2 · Implant
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10381780023586), received between Nov 3, 2023 and Nov 3, 2023 — classified as 1 injury.
1 other recall cover devices cleared under the same FDA submission (K982180); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
Patient problems
- Cerebrospinal Fluid Leakage1
- Meningitis1
- Sepsis1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryNov 3, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
THIS REPORT IS 2 OF 2 REPORTS LINKED TO MFG REPORT NUMBER 3003418325-2023-00014: A LEGAL CLAIM HAS BEEN MADE AGAINST DUREPAIR, FOR WHICH MEDTRONIC HAS REPORTING RESPONSIBILITY. CLAIM DETAILS READ AS FOLLOWS: "HIS PRODUCT WAS A CONFIRMED RECALLED LOT#. HE EXPERIENCED SEVERE COMPLICATIONS, INCLUDING FEVERS (107) SEPSIS AND POSSIBLE MENINGITIS. HE REPORTED THAT HE WAS EXTREMELY ILL, IN CRITICAL CONDITION, AND ALMOST DIED." OPERATIVE NOTES ASSOCIATED WITH THE CLAIM MADE AGAINST DUREPAIR MAKE MENTION OF DURAGEN AND DURASEAL WHICH WERE CONCOMITANTLY USED, AND READ AS FOLLOWS: EXCERPT OF OPERATIVE NOTES OF (B)(6) 2023: PREOPERATIVE DIAGNOSIS: CEREBRAL SPINAL FLUID LEAK, HYPOTHERMIA. POSTOPERATIVE DIAGNOSIS: CEREBRAL SPINAL FLUID LEAK, HYPOTHERMIA. PROCEDURE: REPAIR OF A CSF LEAK, EVACUATION OF PSEUDOMENINGOCELE, REPLACEMENT OF DURAL PATCH WITH BOVINE PERICARDIUM. ¿¿ONCE AGAIN, A SIGNIFICANT AMOUNT OF FLUID WAS NOTED IN THE TISSUES THROUGHOUT THE SURGICAL WOUND. A LARGE SAMPLE OF FLUID WAS THEN SENT TO THE MICROBIOLOGY LAB FOR SAMPLING. MAYO SCISSORS WERE USED TO CUT THE PREVIOUSLY PLACED SUTURES. A CEREBELLAR RETRACTOR WAS THEN PLACED IN THE SURGICAL WOUND TO GET GOOD EXPOSURE. THE PREVIO
Patient problems: Cerebrospinal Fluid Leakage; Meningitis; Sepsis
MAUDE report 18065561 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K982180. One submission often covers many models, so check the product and lot details in each record.
- Z-1282-2013 · Mar 28, 2013 · TerminatedDural Graft Matrix DuraGen Dural Graft Matrix is an absorbable implant for repair of dural defects. DuraGen matrix is an easy to handle, soft, white, pliable, nonfriable, porous
Other DURA SUBSTITUTE devices
- Durepair® 62100Medtronic Ps Medical, Inc. · DURA SUBSTITUTE1 recall6 reports
- Durepair® 62105Medtronic Ps Medical, Inc. · DURA SUBSTITUTE1 recall5 reports
- DuraMatrix Onlay CDSLM45Collagen Matrix, Inc. · Dura Substitute1 recall3 reports
- Durepair® 62110Medtronic Ps Medical, Inc. · DURA SUBSTITUTE1 recall3 reports
- Durepair® 62111Medtronic Ps Medical, Inc. · DURA SUBSTITUTE1 recall1 report
- Durepair® 62106Medtronic Ps Medical, Inc. · DURA SUBSTITUTE1 recall1 report
- Durepair® 62158Medtronic Ps Medical, Inc. · DURA SUBSTITUTE1 recall0 reports
- Biodesign G31091Cook Biotech Incorporated · DURA SUBSTITUTE1 recall0 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page